Banco Bilbao Vizcaya Argentaria, S.A.
BBVABanco Bilbao Vizcaya Argentaria, S.A.'s price has outrun its earnings. +68.8% in a year against EPS +4.8% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +68.8% in a year while annual EPS moved +4.8% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (82 weeks in) while the P/BV sits at the 100th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +10.8% year on year, with the the net margin at 36.1%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Banco Bilbao Vizcaya Argentaria, S.A. trades at $28.1, in a confirmed uptrend and 82 weeks into that stage. That is +22.7% against its own 200-day average. It sits at 100% of a 52-week range of $18 to $28. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is in a confirmed uptrend — week 82 of stage 2. At $28.1 it trades +22.7% versus its 200-day average and sits at 100% of its 52-week range ($18–$28).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +409% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Banco Bilbao Vizcaya Argentaria, S.A. trades at 2.1× P/BV, about the priciest it has ever traded. Its long-run median P/BV is 0.8×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 2.1× is about the priciest it has ever traded, against a long-run median of 0.8× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +68.8% — the price ran ahead of the book, pushing the multiple up its own range.
The price move, decomposed: over 5y, of the +32.9%/yr price move, ~+8.2%/yr came from book-value growth and ~+24.7 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Topping out Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Banco Bilbao Vizcaya Argentaria, S.A. reads as topping out on its fundamental arc. Topping out — profit and EPS growth have decelerated hard (profit growth +26.7% at its peak → +2.6% latest) while ROE still reads 18.8%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: decelerating from a peak is where good stories quietly end — the multiple usually notices late.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +3.8% | +13.0% | — | — |
| Profit | +5.3% | +18.1% | — | — |
| EPS | +4.8% | +21.6% | — | — |
| Stock price | +68.8% | +54.6% | +32.9% | +17.4% |
4-Factor Sector Score
56.6/100 — rank 12 of 18 in Banks - Diversified · 46% evidence confidence · provisional, ranked below fully-evidenced peers
Banco Bilbao Vizcaya Argentaria, S.A. scores 56.6 out of 100 against the 18 companies it is compared with in Banks - Diversified, ranking 12. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 17.1 + 13.7 + 8.6 + 17.2 = 56.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Banco Bilbao Vizcaya Argentaria, S.A. reported $8.8 B of income in the Mar 26 quarter, +11.2% year on year. That is the 3rd straight quarter of year-on-year growth. Over 4 years it has compounded at 14.4% a year. The last full year, FY25, came in at $30.9 B. The last four reported quarters add to $31.8 B.
FY25 revenue came in at $30.9 B (+3.8% on the year), capping 4 years at 14.4% compound. The latest quarter (Mar 26) printed $8.8 B, +11.2% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +3.0% growth against the decade's 14.4% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.0% over the last 4 quarters against +10.5%/yr over the last 8 — rolling over; TTM profit +2.6% vs +14.5%/yr — rolling over.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Banco Bilbao Vizcaya Argentaria, S.A.'s net margin is 36.1% in the Mar 26 quarter, −0.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the net margin has ranged 31.2% to 36.1%. The current quarter sits inside that band.
The latest quarter's net margin is 36.1%, −0.2 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 31.2%–36.1%, and FY25's 36.1% is the top of that band — a record year.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Banco Bilbao Vizcaya Argentaria, S.A. earned $3.2 B of net profit in the Mar 26 quarter, +10.8% year on year. It is the 2nd consecutive quarter of growth. Full-year FY25 profit was $11.1 B. The 4-year compound rate is 18.6%. That is 36.1% of the quarter's revenue. The same quarter a year earlier earned $2.9 B.
Mar 26 profit was $3.2 B, +10.8% year on year — the 2nd consecutive quarter of growth. On the full year, FY25 printed $11.1 B (+5.3%), and the 4-year compound rate is 18.6%.
Why profit moved: revenue contributed +11.2% and the margin −0.2 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +2.6% vs revenue +3.0%. Profit and revenue are moving roughly in step.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Banco Bilbao Vizcaya Argentaria, S.A., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Banco Bilbao Vizcaya Argentaria, S.A.'s revenue grew +3.8% in FY25 to $30.9 B, so the book is growing. The latest quarter ran +11.2% year on year. The net margin on that income is 36.1%, −0.2 percentage points against a year ago.
FY25 revenue was $30.9 B, +3.8% on the year, and the latest quarter ran +11.2% year on year. The net margin on that revenue is 36.1% this quarter (−0.2 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Banco Bilbao Vizcaya Argentaria, S.A. earns a return on equity of 18% in FY25. Its trough over the ladder below was 12% in FY21. On the asset side every $100 of the balance sheet earned about $1.35, which is the return before leverage is applied.
FY25 ROE came in at 18%, recovered from a FY21 trough of 12%. On assets, the latest reading is about 1.35% — every $100 the bank deploys earns roughly $1.35 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 18.6% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Banco Bilbao Vizcaya Argentaria, S.A. paid $1.62 per share over the last four reported quarters, up 46.3% on a year ago. The most recent declaration was $0.60 for Dec 25. Against the current price of $28.1 that is a trailing yield of 5.76%, measured on dividends already paid rather than on a forecast.
Banco Bilbao Vizcaya Argentaria, S.A. paid $1.62 per share across the last four reported quarters, most recently $0.60 for Dec 25. That is up 46.3% against the same quarter a year earlier. Against the current price of $28.1 the trailing twelve months work out to 5.76% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Banco Bilbao Vizcaya Argentaria, S.A., so this section names the gap rather than filling it. At typical trading volumes those positions would take about 0.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Banco Bilbao Vizcaya Argentaria, S.A.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bank of MontrealBMO | 50.9/100Mixed-positive evidence64% evidence | BREAKING OUT | 20.2/35 Income 13.3% · PAT 17.8% 62% evidence | 11.0/25 ROA — · ROE 3.1% · GNPA — 34% evidence | 4.7/20 P/BV 1.69× · P/BV÷ROE 0.55 70% evidence | 15.0/20 RS sector 3.1% · RS bench 13.7% · 1Y 59.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 11 + 4.7 + 15 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2The Bank of New York Mellon CorporationBNY | 49.1/100Mixed-negative evidence60% evidence | LEADER | 18.4/35 Income — · PAT — 26% evidence | 8.8/25 ROA 0.4% · ROE 4% · GNPA — 68% evidence | 4.9/20 P/BV 2.11× · P/BV÷ROE 0.53 70% evidence | 17.0/20 RS sector 4.1% · RS bench 14.8% · 1Y 52.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 8.8 + 4.9 + 17 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Bank of America CorporationBAC | 48.9/100Mixed-negative evidence64% evidence | BREAKING OUT | 22.8/35 Income 15.3% · PAT 19.4% 62% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 6.5/20 P/BV 1.34× · P/BV÷ROE 0.45 70% evidence | 9.2/20 RS sector -4.1% · RS bench 6.3% · 1Y 36.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 10.4 + 6.5 + 9.2 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4JPMorgan Chase & Co.JPM | 48.5/100Mixed-negative evidence64% evidence | TURNING | 20.7/35 Income 13.8% · PAT 15.1% 62% evidence | 13.9/25 ROA — · ROE 5.8% · GNPA — 34% evidence | 6.4/20 P/BV 2.34× · P/BV÷ROE 0.4 70% evidence | 7.5/20 RS sector -7% · RS bench 3.1% · 1Y 23.8%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 13.9 + 6.4 + 7.5 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Canadian Imperial Bank of CommerceCM | 48.1/100Mixed-negative evidence64% evidence | BREAKING OUT | 23.3/35 Income 13.6% · PAT 25.3% 62% evidence | 12.7/25 ROA — · ROE 3.9% · GNPA — 34% evidence | 4.5/20 P/BV 2.11× · P/BV÷ROE 0.54 70% evidence | 7.6/20 RS sector -0.1% · RS bench 10.1% · 1Y 62.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 12.7 + 4.5 + 7.6 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6HSBC Holdings plcHSBC | 47.9/100Mixed-negative evidence62% evidence | TURNING | 12.0/35 Income 7.6% · PAT 5.6% 55% evidence | 12.2/25 ROA — · ROE 3.7% · GNPA — 34% evidence | 7.4/20 P/BV 1.44× · P/BV÷ROE 0.39 70% evidence | 16.3/20 RS sector 5.5% · RS bench 16.2% · 1Y 66.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 12 + 12.2 + 7.4 + 16.3 = 47.9 · Decision use: Price leads the evidence: RS versus the benchmark is 16.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Royal Bank of CanadaRY | 47.2/100Mixed-negative evidence64% evidence | BREAKING OUT | 20.8/35 Income 13% · PAT 21.5% 62% evidence | 13.1/25 ROA — · ROE 4% · GNPA — 34% evidence | 3.0/20 P/BV 2.41× · P/BV÷ROE 0.6 70% evidence | 10.3/20 RS sector 0.4% · RS bench 10.7% · 1Y 57.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 13.1 + 3 + 10.3 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Citigroup Inc.C | 45.4/100Mixed-negative evidence64% evidence | TURNING | 23.3/35 Income 12.9% · PAT 27.8% 62% evidence | 9.2/25 ROA — · ROE 2.8% · GNPA — 34% evidence | 8.6/20 P/BV 0.59× · P/BV÷ROE 0.21 70% evidence | 4.3/20 RS sector -3.1% · RS bench 6.9% · 1Y 47.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 9.2 + 8.6 + 4.3 = 45.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.1% and the one-year return is 47.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9The Bank of Nova ScotiaBNS | 44.2/100Mixed-negative evidence64% evidence | BREAKING OUT | 22.8/35 Income 11.5% · PAT 45.9% 62% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 5.6/20 P/BV 1.49× · P/BV÷ROE 0.5 70% evidence | 5.4/20 RS sector -3.1% · RS bench 7% · 1Y 55.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 10.4 + 5.6 + 5.4 = 44.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.1% and the one-year return is 55.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Wells Fargo & CompanyWFC | 38.5/100Mixed-negative evidence64% evidence | TURNING | 13.1/35 Income 7% · PAT 10.6% 62% evidence | 11.9/25 ROA — · ROE 3.6% · GNPA — 34% evidence | 7.7/20 P/BV 1.39× · P/BV÷ROE 0.39 70% evidence | 5.8/20 RS sector -15.1% · RS bench -5.8% · 1Y 13.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 11.9 + 7.7 + 5.8 = 38.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11The Toronto-Dominion BankTD | 31.8/100Adverse evidence64% evidence | LEADER | 6.6/35 Income -4.5% · PAT -10.7% 62% evidence | 10.9/25 ROA — · ROE 3.4% · GNPA — 34% evidence | 3.9/20 P/BV 1.94× · P/BV÷ROE 0.57 70% evidence | 10.4/20 RS sector 1.7% · RS bench 12% · 1Y 63%12 of 12 weeks ahead 100% evidence |
| Exact sum: 6.6 + 10.9 + 3.9 + 10.4 = 31.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Banco Bilbao Vizcaya Argentaria, S.A.this pageBBVA | 56.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.1/35 Income — · PAT — 10% evidence | 13.7/25 ROA — · ROE 5.3% · GNPA — 34% evidence | 8.6/20 P/BV 1.62× · P/BV÷ROE 0.31 70% evidence | 17.2/20 RS sector 3.1% · RS bench 13.8% · 1Y 51.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 13.7 + 8.6 + 17.2 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13ING Groep N.V.ING | 51.3/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.5/35 Income — · PAT — 10% evidence | 12.4/25 ROA — · ROE 3.8% · GNPA — 34% evidence | 6.8/20 P/BV 1.56× · P/BV÷ROE 0.41 70% evidence | 14.6/20 RS sector 3% · RS bench 13.7% · 1Y 44.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 12.4 + 6.8 + 14.6 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Forbright, Inc.FRBT | 47.6/100Thin evidence · provisional10% evidence | 18.0/35 Income — · PAT — 3% evidence | 9.6/25 ROA — · ROE 0.9% · GNPA — 34% evidence | 10.0/20 P/BV — · P/BV÷ROE — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 18 + 9.6 + 10 + 10 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Banco Santander, S.A.SAN | 46.6/100Thin evidence · provisional46% evidence | BREAKING OUT | 16.7/35 Income — · PAT — 10% evidence | 11.4/25 ROA — · ROE 3.3% · GNPA — 34% evidence | 6.2/20 P/BV 1.58× · P/BV÷ROE 0.48 70% evidence | 12.3/20 RS sector 1.6% · RS bench 12.1% · 1Y 55.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 11.4 + 6.2 + 12.3 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Barclays PLCBCS | 45.3/100Thin evidence · provisional46% evidence | BREAKING OUT | 17.1/35 Income — · PAT — 10% evidence | 10.4/25 ROA — · ROE 3% · GNPA — 34% evidence | 8.1/20 P/BV 1.04× · P/BV÷ROE 0.34 70% evidence | 9.7/20 RS sector -3% · RS bench 7.1% · 1Y 40.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 10.4 + 8.1 + 9.7 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17UBS Group AGUBS | 42.9/100Thin evidence · provisional46% evidence | LEADER | 16.9/35 Income — · PAT — 10% evidence | 10.1/25 ROA — · ROE 3.1% · GNPA — 34% evidence | 4.3/20 P/BV 1.7× · P/BV÷ROE 0.55 70% evidence | 11.6/20 RS sector -0.2% · RS bench 10.3% · 1Y 35.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 10.1 + 4.3 + 11.6 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18The Bank of N.T. Butterfield & Son LimitedNTB | 42.9/100Thin evidence · provisional46% evidence | TURNING | 16.3/35 Income — · PAT — 10% evidence | 13.4/25 ROA — · ROE 4.2% · GNPA — 34% evidence | 5.6/20 P/BV 2.04× · P/BV÷ROE 0.48 70% evidence | 7.6/20 RS sector -1.6% · RS bench 8.6% · 1Y 38%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 13.4 + 5.6 + 7.6 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Banco Bilbao Vizcaya Argentaria, S.A.'s stock price today?
Banco Bilbao Vizcaya Argentaria, S.A. trades at $28.1, +68.8% over the past year. The company is valued at $157 B. The stock sits at 100% of its 52-week range of $18–$28, +22.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 82 weeks in. — as of 5 August 2026.
What were Banco Bilbao Vizcaya Argentaria, S.A.'s latest quarterly results?
Banco Bilbao Vizcaya Argentaria, S.A. reported total income of $8.8 B and net profit of $3.2 B for the Mar 26 quarter. Income rose 11.2% and profit rose 10.8% year on year. Earnings per share were $0.51. The net margin was 36.1%, 0.2 pp lower than a year earlier. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s revenue?
Banco Bilbao Vizcaya Argentaria, S.A. reported revenue of $8.8 B in the Mar 26 quarter, +11.2% year on year. For the full FY25 fiscal year, revenue was $30.9 B (+3.8%). Over the last 4 years revenue compounded at 14.4% a year. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s profit?
Banco Bilbao Vizcaya Argentaria, S.A. earned $3.2 B of net profit in the Mar 26 quarter, +10.8% year on year — the 2nd straight quarter of growth. Full-year FY25 profit was $11.1 B. The net margin ran 36.1% in the latest quarter. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s market cap?
Banco Bilbao Vizcaya Argentaria, S.A.'s market capitalisation is $157 B at a stock price of $28.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s P/BV ratio?
Banco Bilbao Vizcaya Argentaria, S.A. trades at a P/BV of 2.1×, at the 100th percentile of its own 5-year range, against a long-run median of 0.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Banco Bilbao Vizcaya Argentaria, S.A. pay a dividend?
Yes — Banco Bilbao Vizcaya Argentaria, S.A. declared $0.60 per share for Dec 25, and $1.62 per share across the last four reported quarters. The latest quarter is up 46.3% on the same quarter a year earlier. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s dividend per share?
Banco Bilbao Vizcaya Argentaria, S.A.'s most recently declared dividend is $0.60 per share for Dec 25, giving $1.62 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Banco Bilbao Vizcaya Argentaria, S.A.'s dividend yield?
Banco Bilbao Vizcaya Argentaria, S.A.'s trailing dividend yield is 5.76%: $1.62 declared per share across the last four reported quarters, against a share price of $28.1. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A. overvalued?
On its own history, Banco Bilbao Vizcaya Argentaria, S.A. looks expensive against its own history: its P/BV of 2.1× sits at the 100th percentile of its 5-year range (long-run median 0.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: the net margin is the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A. growing?
Yes — Banco Bilbao Vizcaya Argentaria, S.A. is growing: latest-quarter revenue +11.2% year on year, profit +10.8%, and the the net margin −0.2 pp at 36.1%. The 4-year compound rates are 14.4% (revenue) and 18.6% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Banco Bilbao Vizcaya Argentaria, S.A. performing?
Banco Bilbao Vizcaya Argentaria, S.A. is in a confirmed uptrend, 82 weeks in. Its latest quarter's income rose 11.2% and profit rose 10.8% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Banco Bilbao Vizcaya Argentaria, S.A. in?
Topping out — profit and EPS growth have decelerated hard (profit growth +26.7% at its peak → +2.6% latest) while ROE still reads 18.8%. The read comes from the last 12 quarters of growth (revenue growth +3.0% latest, profit growth +2.6% latest, eps growth +2.8% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A. in an uptrend?
Yes — the price is in a confirmed uptrend (week 82 of stage 2), trading +22.7% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A. beating the market?
On recent form, yes — Banco Bilbao Vizcaya Argentaria, S.A. has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +409% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.
Will Banco Bilbao Vizcaya Argentaria, S.A.'s stock price go up?
This page publishes no price forecast for Banco Bilbao Vizcaya Argentaria, S.A. What it measures instead: the stock price is $28.1, the price is in a confirmed uptrend 82 weeks in. Its P/BV of 2.1× sits at the 100th percentile of its own 5-year range. — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Banco Bilbao Vizcaya Argentaria, S.A., so this page says that plainly. The cleanest available reads are revenue growth (+3.8% in FY25) and the net margin on it (36.1%) — as of 5 August 2026.
Where is Banco Bilbao Vizcaya Argentaria, S.A. in its business cycle?
Banco Bilbao Vizcaya Argentaria, S.A.'s FY25 net margin was 36.1%, against a 5-year band of 31.2%–36.1%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 36.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Banco Bilbao Vizcaya Argentaria, S.A. story?
The sharpest disagreement: the price moved +68.8% in a year while annual EPS moved +4.8% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Banco Bilbao Vizcaya Argentaria, S.A. a stock worth studying right now?
This is not investment advice. The machine read: Banco Bilbao Vizcaya Argentaria, S.A.'s price has outrun its earnings. +68.8% in a year against EPS +4.8% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.